Objectives: To examine rates of hospice disenrollment and posthospice hospitalization among patients who are enrolled in hospices that provide continuous home care (CHC) (CHC hospices) compared with patients who are enrolled in hospices that do not offer CHC (non-CHC hospices).
H ospice has been embraced as an indicator of high quality in end-of-life care, 1 but even among hospice enrollees, disenrollment, and hospitalization rates are substantial. 2, 3 Recent evidence has indicated that >10% of hospice users experience disenrollment from hospice before death, and approximately half of them are hospitalized. 4 Among nursing home residents, 24% of hospice users experienced posthospice hospitalization in the last 30 days of life. 5 Disenrollment and hospitalization not only produce substantial patient and family burden 6 but also increase costs of care at the end of life. 7 Previous studies have examined factors associated with hospice disenrollment and posthospice hospitalization. Patient comorbidity has been found significantly associated with increased rates of disenrollment and hospitalization. 8 Hospicelevel characteristics also play important roles, as the disenrollment rates have been found to be higher in newer hospices, smaller hospices, and hospices in more competitive markets. 4 Another important factor is the level of hospice care provided. Among 4 levels of hospice care, continuous home care (CHC) provides intensive care at home and has the highest reimbursement rate. 9, 10 Medicare regulations require that CHC may be provided only during a period of crisis to maintain an individual at home. During a 24-hour day, the hospice must provide a minimum of 8 hours of nursing, hospice aide, and/or homemaker care, and the services provided must be predominantly nursing care. 9 Although studies have found that patients who use CHC are less likely to disenroll or be hospitalized in last 6 months of life, [11] [12] [13] no studies have examined whether hospices that offer CHC (CHC hospices) compared with those do not (non-CHC hospices) differ in terms of disenrollment and posthospice hospitalization rates. Furthermore, we do not know how the effect of CHC provision may differ for larger and smaller hospices. Nor do we know if a threshold effect exists, by which hospices in which at least some percentage of patients use CHC have lower disenrollment and hospitalization rates. Accordingly, we conducted an exploratory study to examine the hospice-level variation of hospice disenrollment and posthospice hospitalization rates. We hypothesized that CHC hospices would have lower hospice disenrollment and hospitalization rates compared with non-CHC hospices. We also anticipated that this effect would be more pronounced for larger hospices and for those in which a larger percentage of patients used CHC. We applied a novel approach to mimic a cluster randomized controlled trial. Using propensity score matching (PSM) approach, we identified and compared CHC and non-CHC hospices with similar hospice characteristics (ownership, geographic region, size, and operation duration). Findings from this study could advance our understanding of potential benefits of CHC, particularly as hospice disenrollment and hospitalization have been linked with significantly increased costs at the end of life.
METHODS

Study Design and Sample
We designed a retrospective cohort study with a population of all fee-for-service Medicare beneficiaries older than 66 years who died between July 1, 2011 and December 31, 2011. We retrieved their demographics and chronic conditions from the Master Beneficiary Summary File, as well as inpatient and hospice Medicare claims in the 6 months before death. Using their hospice claim data, we limited the study population to those who had at least 1 hospice claim to the Centers for Medicare & Medicaid Services (CMS) within 6 months before death. We obtained hospice characteristics from the Provider of Services file. Applying PSM, we assessed the relationship between CHC provision and rates of hospice disenrollment and posthospice hospitalization. For the hospices, we excluded hospices that had r14 enrollees during the study period (n = 720) and had missing hospice characteristics (n = 11). The institutional review board of Yale University have reviewed the study, which was exempt from full review.
Intervention and Outcome Ascertainment
Per CMS Manual System, 14,15 we used the revenue center code values of 0652 to determine which hospice programs provided CHC based on the definition of having at least 1 patient who received CHC during the study period. To ascertain outcomes, we created 2 binary variables to indicate if the patient got disenrolled from hospice or if the patient was hospitalized after hospice disenrollment. Hospice disenrollment was defined as if: first, they had only 1 hospice enrollment period and the last hospice date on the final hospice claim was not the date of death; or second, if they had >1 hospice enrollment period. Hospitalization was determined by the presence of hospitalization claims. For the decedent who had >1 hospice provider in the study period, we assigned the first hospice provider to the decedent in the analyses.
Statistical Analysis
PSM and Hospice-level Covariates
To minimize the selection bias at the hospice level, we used the PSM method, which mimics a cluster randomized controlled trial in our observational setting. Using logistic regression, including 4 hospice covariates listed in the previous section, we estimated for each hospice the probability of providing CHC. The PSM controlled for 4 hospice characteristics: Using the Provider of Services file, we determined hospice ownership type (for-profit and nonprofit), hospice's location (rural vs. urban), and duration of hospice operation (years: <10, 10-18, 19-23, and Z24). We also counted the number of admissions (measured as the number of individuals enrolled during the study period by each hospice) and categorized it into quartiles.
We used 1:1 nearest neighbor matching without replacement. The caliper was set as 0.75 SD to maximize sample size and to ensure matching quality. Each matched pair contained a CHC hospice and a non-CHC hospice with similar hospice characteristics. Balance diagnostics were assessed by comparing prevalence of baseline characteristics using standardized differences (expressed as a percentage). 16 Prior research has suggested that a standardized difference (absolute value) Z10 indicates meaningful imbalance in the baseline covariate. 17 
Fully Adjusted Model and Patient-level Covariates
In our fully adjusted model, we analyzed hospice users enrolled in the matched hospices, controlling for patientlevel covariates. Patient demographics included age (categorized as 66-69, 70-74, 75-79, 80-84, and Z85 y), sex, race (non-Hispanic white, non-Hispanic black, Hispanic, and other), primary diagnosis for hospice enrollment (including neoplasms, mental disorders, disease of nervous system, disease of circulatory system, disease of respiratory system, illness-defined conditions and other). Using data from the Master Beneficiary Summary File, we ascertained 8 chronic conditions, including heart disease, Alzheimer disease or dementia, kidney disease, diabetes, chronic obstructive pulmonary disease or asthma, depression, stroke, and cancer. We then categorized decedents based on their count of comorbid conditions. We also adjusted for time from hospice enrollment to death (a continuous variable from 0 to 179 d). We identified the county of residence for each beneficiary using zip code information. We examined data pertaining to the county in which the patient resided using the Area Resource File. We then constructed 2 ecological variables, including median county-level income and percentage of adults in the county with a high school education or less.
Primary Analysis
In the matched sample, we examined the mean percentage of hospice disenrollment and posthospice hospitalization at hospice level for CHC hospices and non-CHC hospices. We used Poisson regression models, clustering enrollees by individual hospices, to examine rates of hospice disenrollment, and hospitalization between CHC hospices versus non-CHC hospices. The generalized estimating equation models were also clustered by matched sets to allow for correlation between matched pairs of hospices by status of CHC provision. For each outcome of interest, we further adjusted for decedents characteristics, as described in the previous section. Adjusted rate ratios (ARRs) were reported. We used at least 15 hospice enrollees per hospice in our analyses to avoid biased regression coefficients. 18 We also conducted sensitivity analyses, using the cut-off value of 5 or 25 hospice enrollees.
Subgroup Analysis
We conducted additional subgroup analyses to explore whether the associations between CHC and outcomes differed by hospice characteristics. We acknowledged that the pair in the PSM sample might have unmatched characteristics. For instance, a nonprofit CHC hospice could match with a forprofit non-CHC hospice. Therefore, we included the whole eligible hospices and enrollees before PSM, and used Poisson regression models, controlling for patient and hospice characteristics and including interaction terms between CHC status and hospice characteristics. Subgroup analyses were conducted for those hospice characteristics where a significant interaction exists. We dichotomized hospice size and duration of operation into large versus small hospices and young versus old hospices, based on the median number of enrollees or median length of operation in our sample. Subgroup analyses on percentage of CHC use were performed among the post-PSM population because there was no mismatching issue. Using our PSM sample, we categorized CHC hospices into quintiles based on the percentage of enrollees who received CHC. Each subgroup contained CHC hospice in this quintile and their matched non-CHC hospices. We examined the ARR for each subgroup. All analyses were conducted using SAS (version 9.4; SAS Institute, Cary, NC). Tests were 2-sided with an a of 0.05.
RESULTS
Sample Characteristics
Our original sample consisted of 311,090 hospice users in 3509 hospices. After excluding hospice with r14 enrollees or those with missing hospice characteristics, we retained data for 305,498 Medicare hospice users (98.2% of the original sample) who were enrolled in 2778 hospices (Fig. 1) . Among these hospices, 1100 (39.6%) hospices provided CHC services to at least one of their enrollees. After PSM, we generated 936 hospice pairs, each containing 1 CHC hospice and 1 non-CHC hospice. Those hospices we excluded through PSM were more likely to be nonprofit and rurally located. After matching, hospice characteristics between those who provided CHC and those who did not were well balanced, with standardized differences <10%. A total of 103,803 decedents were enrolled in CHC hospices and 88,869 decedents were enrolled in non-CHC hospices (Table 1) . Although patient characteristics were not included in the model for PSM, they were also well balanced, with the exception that decedents who had lived in zip codes in which >90% of the population had a high school education or less were more common in non-CHC hospices (standardized difference, À 10.9). In CHC hospices, the crude mean percentage of decedents who had hospice disenrollment was 12.9% and the percentage of decedents who had posthospice hospitalization was 7.5%; whereas in non-CHC hospices, the crude percentage was 12.0% and 6.8%, respectively ( Table 2) . 
Hospice Offering of CHC and Disenrollment and Hospitalization Rates
When we clustered hospice enrollees by hospices and adjusted for patient characteristics, the ARRs between CHC hospices versus non-CHC hospices on hospice disenrollment or hospitalization were statistically significantly different from 1 (Table 3) . Compared with non-CHC hospices, CHC hospices had a significantly lower rate of hospice disenrollment [ARR = 0.73; 95% confidence interval (CI), 0.60-0.87; P < 0.001] and a significantly lower rate of hospitalization (ARR = 0.79; 95% CI, 0.66-0.95; P = 0.014). Hospice enrollees who were older, female, or white were less likely to have hospice disenrollment or posthospice hospitalization, compared with those who were younger, male, or nonwhites (P < 0.05).
Interaction and Subgroup Analyses
We found a statistically significant interaction with hospice size (interaction P < 0.001 for hospice disenrollment and P < 0.002 for hospitalization), in which the association between being a CHC hospice and hospice disenrollment or hospitalization differed by the hospice size. Among small hospices (r175 enrollees in the study period), offering CHC was not significantly associated with the outcomes of interest, with ARRs of 0.92 (95% CI, 0.83-1.02) for hospice disenrollment rates and 0.97 (95% CI, 0.86-1.08 for hospitalization rates (Fig. 2) . In contrast, among large hospices (Z176 enrollees in the study period), offering CHC was associated with decreased hospice disenrollment and hospitalization rates, with ARRs of 0.52 (95% CI, 0.42-0.64) and 0.61 (95% CI, 0.49-0.76), respectively. Interaction effects were not significant for ownership type, urban/rural location, or duration of hospice operation (P > 0.20 except 0.07 for location with hospitalization rate).
We also found that the associations between enrollment in CHC hospice and the likelihood of hospice disenrollment were significantly modified by the percentage of patients who received CHC (Fig. 3A) . Among hospices where the <7.3% of patients used CHC (the lowest 3 quintiles), the effect of being cared for by a CHC hospice on disenrollment was nonsignificant. For instance, CHC hospices in which <7.3% of enrollees used CHC had an ARR of 0.98 (95% CI, 0.78-1.22) on hospice disenrollment, compared with their matched non-CHC hospices. In contrast, among hospices with at least 7.3% but <20.8% of patients using CHC (the second highest quintile), the effect was significant as the ARR of hospice disenrollment for CHC versus non-CHC hospices was 0.52 (95% CI, 0.35-0.77). Interestingly, among hospices in which CHC was used by >20.8% of enrollees (highest quintile), the ARR of hospice disenrollment in comparison with non-CHC hospices did not further decrease (ARR = 0.56; 95% CI, 0.36-0.88). Similar patterns were apparent for the outcome of posthospice hospitalization rate (Fig. 3B) . Sensitivity analyses, varying the cut-off value of 5 or 25 enrollees, reached similar conclusions (data not shown; available from the first author upon request).
DISCUSSION
Although the Medicare Hospice Benefit requires hospices to provide CHC, less than half of hospice providers had CHC claims in 2011. In this study, we found that hospices that provided CHC services had lower rates of hospice disenrollment or hospitalization than hospices which did not provide CHC services. Previous evidence has suggested that within CHC hospices, hospice enrollees who use CHC services may have better outcomes, including a decrease in hospice disenrollment or hospitalization at the end of life. [11] [12] [13] Prior studies, however, analyzed data of CHC hospice enrollees only and were unable to examine whether hospice's offering of CHC may mitigate risks of disenrollment and hospitalization. In this first study comparing CHC and non-CHC hospices, we found that CHC hospices perform better in terms of reduced disenrollment and hospitalization, providing important information for patients and their family or physicians considering alternative hospice providers. The findings may also be useful for policy makers seeking indicators of quality in end-of-life care.
Our findings build upon previous work in important ways. First, the associations between CHC provision and hospice performance differed by hospice size. Our findings were consistent with the concept of scale economy: with increasing size, hospices may be able to provide CHC efficiently; whereas small hospices may struggle providing labor-intensive CHC services, given limited nursing staff. 19 According to Medicare hospice benefits, CHC services are provided by a licensed nurse for at least 50% of care hours and up to 24 hours per day. 19, 20 These services are offered as a last resort for those having complex needs. Furthermore, these nurses have to be considered employees of the hospice, and hospices cannot contract nurses on a regular basis to provide CHC. 9 As a consequence, small hospices are less likely to be able to provide CHC. Even if small hospices could provide CHC, they may have logistic issues, such as staffing shortage, which may compromise their performances. Enabling smaller hospices to provide CHC and routine hospice services simultaneously to their enrollees would be an important task for policy makers who seek to promote CHC. For instance, the CMS may allow small hospices, such as those in the rural areas, to provide CHC through contracting hospitals or nurses. Second, our findings suggest there may be a minimum percentage of patients who receive CHC services for a resulting decrease in hospice disenrollment and posthospice hospitalization to be observed. We found that hospices which provided CHC services to a small percentage of their enrollees did not perform better than non-CHC hospices. Plausible explanations included that the CHC services offered in these hospices did not meet the needs of hospice enrollees; thus, they could not prevent disenrollment or hospitalization. For instance, these hospices might lack protocol or criteria for instituting CHC. In addition, they might not have sufficient capacity to address enrollee's demand. Indeed, literature has suggested that the initiation of CHC is challenging. 21 Because of limited staffing, only very few patients are able to receive CHC; therefore, some hospice enrollees who need CHC to avoid disenrollment cannot get it. Staff in these hospices might also lack experience or training to provide CHC in a timely manner.
Third, we found that while hospices with 7.3%-20.8% of their enrollees using CHC had significantly lower disenrollment and hospitalization rates, having even higher CHC use rates did not confer additional reductions in these outcomes. Literature suggested that the percentage of hospice enrollees who received CHC differed substantially across CHC hospices and, in some hospices, exceeded 75%. 13, 22 There have been concerns about overuse of health care services in the United States 23 ; and there have been potential fraud hospice claims. 24 Our results suggest that this very high utilization of CHC among some hospices is unlikely to reduce disenrollment and hospitalization rates. Although CHC use should be consistent with patient and family conditions and needs, our data suggest a potential benchmark of between 7% and 20% for the percentage of enrollees receiving CHC. Fourth, we applied a novel approach to mimic a cluster randomized controlled trial. Propensity score methodology has been developed to reduce biases in outcomes research, yet most studies applying this approach created a pseudorandomization at individual level. In this study, we used a PSM approach to create pairs, matching hospices which provided CHC services to hospices which did not provided CHC services. We identified patient characteristics and adjusted for these factors. Furthermore, we used Poisson regression clustering enrollees within each hospice; thus, we were able to mitigate potential confounding due to the hierarchical structure of data. For instance, the interpretation based on the crude percentages of posthospice hospitalization rates in the CHC and non-CHC hospices were biased, potentially driven by small hospices. Our approach could be used to examine the effects of other interventions at hospice or hospital level.
Our findings should be interpreted in light of several limitations. As an observational design with a short time period for the study, we could not establish causal inferences, although we used PSM and adjusted for patient characteristics to reduce bias. In addition, we defined CHC hospices when they had at least 1 CHC Medicare claim, which may have measurement errors. Although hospices use the revenue code 0652 to bill Medicare for CHC services and CHC has the highest reimbursement rate among 4 levels of hospice care, using this code to capture CHC has not been validated. We also acknowledge that we lack information about how and when hospices decided to offer CHC. Our results are not generalizable to the hospices excluded from our analyses because they did not have a match in our PSM process. Finally, we lacked data on patient preferences regarding CHC hospices and non-CHC hospices. It is, however, unlikely that patients who elected a CHC hospice systematically differed from those who elected a non-CHC hospices, given that the patient characteristics were very similar after PSM of hospice-level characteristics. Nevertheless, understanding the patient and family roles in disenrollment and hospitalization events would help end-of-life care be consistent with patient preferences. To address this important issue, future research is needed.
In conclusion, hospices that offered CHC compared with those that did not offer CHC had significantly lower rates of hospice disenrollment and hospitalization. These effects were more prominent among hospices that were larger and had a substantial portion of enrollees using CHC services. Our findings suggest that programs to promote the offering of CHC by hospices may help avert disenrollment and hospitalization, potentially reducing unnecessary family burden and end-of-life costs of care. . Adjusted rate ratios of (A) hospice disenrollment and (B) posthospice hospitalization, CHC hospices versus non-CHC hospices according to the percentage of enrollees receiving CHC, propensity score-matched sample. The percentage of enrollees receiving CHC were categorized into quintiles as: first quintile <1.7%; second quintile 1.7%-3.6%; third quintile 3.6%-7.3%; fourth quintile 7.3%-20.8%; fifth quintile Z20.8%. CHC indicates continuous home care. 
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Small hospices Large hospices FIGURE 2. Adjusted rate ratios of hospice disenrollment and posthospice hospitalization, CHC hospices versus non-CHC hospices according to hospice size, entire cohort. Non-CHC hospices; hospices with <176 enrollees during study period (median number of enrollees in our sample) were classified as small hospices. CHC indicates continuous home care.
